Subscribe
Sean Ong discusses how persistent fever beyond 72 hours emerges as a stronger predictor of mortality in MRSA bacteremia compared to CRP and WBC counts.
Investigational Staphylococcus aureus Vaccine Begins Phase 1 Study
Shifting Patterns of Staphylococcus aureus Infections in Pediatric Patients
Similar Efficacy of Ceftaroline and Vancomycin in Treating Complicated Skin and Soft Tissue Infections
Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc
Filipa Lynce, MD; Rita Nanda, MD
Suneel Udani, MD
Kamel Abou Hussein, MD
Syma Iqbal, MD; Benjamin Scheier, MD
Rahul Gosain, MD, MBA; Rohit Gosain, MD; Hossein Borghaei, DO, MS
Krish Patel, MD; Matthew Ulrickson, MD
Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD
Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD
Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc; Filipa Lynce, MD; Rita Nanda, MD; Tiffany A. Traina, MD, FASCO
Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD
David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD
Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD